Email Alerts
RSS
Volume 38 Issue 8
Aug.  2022
Turn off MathJax
Article Contents
Article Navigation >  CHINESE JOURNAL OF BURNS AND WOUNDS  > 2022  >  38(8): 722-734
Lou Jiaqi,Li Qi,Cui Qingwei,et al.A prospective randomized controlled study on the curative effects of enteral immunonutrition support therapy in adult burn patients at nutritional risk[J].Chin J Burns Wounds,2022,38(08):722-734.DOI: 10.3760/cma.j.cn501225-20220327-00094.
Citation: Lou Jiaqi,Li Qi,Cui Qingwei,et al.A prospective randomized controlled study on the curative effects of enteral immunonutrition support therapy in adult burn patients at nutritional risk[J].Chin J Burns Wounds,2022,38(08):722-734.DOI: 10.3760/cma.j.cn501225-20220327-00094.
shu

A prospective randomized controlled study on the curative effects of enteral immunonutrition support therapy in adult burn patients at nutritional risk

doi: 10.3760/cma.j.cn501225-20220327-00094

  • Department of Burns and Plastic Surgery, the 71st Group Army Hospital of Army, Affiliated Huaihai Hospital of Xuzhou Medical University, Xuzhou 221004, China

Funds:

General Program of National Natural Science Foundation of China 81772082

More Information
    Abstract
  •   Objective  To explore the effects of enteral immunonutrition support therapy on nutritional metabolism, immune function, and inflammatory response in adult burn patients at nutritional risk as assessed by the modified 2nd nutrition risk screening (NRS) 2002.  Methods  A prospective randomized controlled study was conducted. From December 2019 to January 2022, 500 adult patients who were admitted to the Affiliated Huaihai Hospital of Xuzhou Medical University and had nutritional risk assessed by the modified 2nd NRS 2002 were recruited into the study. According to burn severity, the patients were divided into common burn patients (n=450) and severe burn patients (n=50). According to the random number table, the patients with common burn were divided into common burn diet nutrition group and common burn diet enteral immunonutrition group, with 225 patients in each group, and the patients with severe burn were divided into severe burn diet enteral non-immunonutrition group and severe burn diet enteral immunonutrition group, with 25 patients in each group. The patients in each group were given the corresponding nutritional support therapies on the basis of routine burn treatment. On post injury day (PID) 1, 3, 7, 14, and 21, the total energy intake and total protein intake of the patients in 4 groups were recorded, the plasma prealbumin, albumin, transferrin, serum immunoglobulin A (IgA), IgG, IgM, peripheral blood CD3 positive T cell percentage, CD4 positive T cell count, CD8 positive T cell count, the ratio of CD4 positive T cells to CD8 positive T cells, natural killer cell percentage, plasma interleukin-6 (IL-6), free mitochondrial DNA (mtDNA) copy number, and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) of the patients in 4 groups were detected, and the nitrogen balance of the patients in 4 groups on the day was calculated. On PID 7, 14, and 21, the modified 2nd NRS 2002 scores of the patients in 4 groups were reassessed. The sepsis incidence during treatment and the length of hospital stay of the patients in 4 groups and the length of intensive care unit (ICU) stay of the patients in the 2 severe burn groups were recorded. Data were statistically analyzed with chi-square test, Fisher's exact probability test, Mann-Whitney U test, independent sample t test, analysis of variance for repeated measurement, and Bonferroni correction.  Results  A total of 476 patients completed the trial, with 213 patients in common burn diet nutrition group (112 males and 101 females, aged (37±19) years), 218 patients in common burn diet enteral immunonutrition group (115 males and 103 females, aged (42±16) years), 22 patients in severe burn diet enteral non-immunonutrition group (11 males and 11 females, aged (35±8) years), and 23 patients in severe burn diet enteral immunonutrition group (12 males and 11 females, aged (35±8) years). Compared with those in common burn diet nutrition group, the patients in common burn diet enteral immunonutrition group had significantly higher total energy intake on PID 1 (t=6.06, P<0.01), significantly lower total energy intake on PID 7 and significantly lower total protein intake on PID 1 (with t values of 6.17 and 4.59, respectively,P<0.01). On PID 21, the total energy intake of patients in severe burn diet enteral immunonutrition group was significantly lower than that in severe burn diet enteral non-immunonutrition group (t=2.70, P<0.01). The total protein intake of patients in severe burn diet enteral immunonutrition group and severe burn diet enteral non-immunonutrition group were similar at each time point post injury (P>0.05). Compared with those in common burn diet nutrition group, the patients in common burn diet enteral immunonutrition group had significantly higher level of prealbumin on PID 3, 7, 14, and 21 (with t values of 2.05, 2.33, 2.45, and 2.11, respectively, P<0.05), significantly higher level of albumin on PID 7, 14, and 21 (with t values of 2.30, 2.56, and 2.15, respectively, P<0.05), significantly higher level of transferrin on PID 7 and 14 (with t values of 1.99 and 2.27, respectively, P<0.05), significantly higher nitrogen balance on PID 14 and 21 (with t values of 2.51 and 2.07, respectively, P<0.05), and significantly lower modified 2nd NRS 2002 score on PID 21 (t=1.99, P<0.05). Compared with those in severe burn diet enteral non-immunonutrition group, the patients in severe burn diet enteral immunonutrition group had significantly higher level of prealbumin on PID 3, 7, 14, and 21 (with t values of 2.50, 2.64, 2.18, and 2.39, respectively, P<0.05), significantly higher level of albumin​on PID 7, 14, and 21 (with t values of 2.27, 2.39, and 2.69, respectively, P<0.05), significantly higher level of transferrin and nitrogen balance but significantly lower modified 2nd NRS 2002 score on PID 14 and 21 (with t values of 2.30, 2.35, 2.41, 2.16, 2.31, and 2.73, respectively, P<0.05). Compared with those in common burn diet nutrition group, patients in common burn diet enteral immunonutrition group had significantly higher level of IgA and IgG on PID 7, 14, and 21 (with t values of 2.19, 2.36, 2.17, 2.49, 1.97, and 2.24, respectively, P<0.05), significantly higher level of IgM on PID 21 (t=2.06, P<0.05), significantly higher percentage of CD3 positive T cells and ratio of CD4 positive T cells to CD8 positive T cells on PID 3, 7, 14, and 21 (with t values of 2.49, 2.25, 2.33, 2.41, 2.39, 2.24, 2.46, and 2.18, respectively, P<0.05), significantly higher CD4 positive T cell count (with t values of 2.15 and 2.27, respectively, P<0.05) but significantly lower CD8 positive T cell count on PID 14 and 21 (with t values of 2.58 and 2.35, P<0.05), and significantly higher percentage of natural killer cells on PID 7, 14, and 21 (with t values of 2.53, 2.21, and 2.36, respectively, P<0.05). Compared with those in severe burn diet enteral non-immunonutrition group, patients in severe burn diet immunonutrition group had significantly higher level of IgA on PID 7 and 14 (with t values of 2.15 and 2.03, respectively, P<0.05), significantly higher level of IgG on PID 7, 14, and 21 (with t values of 2.09, 2.56, and 2.15, respectively, P<0.05), significantly higher level of IgM on PID 21 (t=2.08, P<0.05), significantly higher percentage of CD3 positive T cells, CD4 positive T cell count, and percentage of natural killer cells on PID 14 and 21 (with t values of 2.52, 2.14, 2.14, 2.39, 2.56, and 2.19, respectively, P<0.05), significantly lower CD8 positive T cell count but significantly higher ratio of CD4 positive T cells to CD8 positive T cells on PID 7, 14, and 21 (with t values of 2.27, 2.81, 2.01, 2.11, 2.69, and 2.05, respectively, P<0.05). Compared with those in common burn diet nutrition group, patients in common burn diet enteral immunonutrition group had significantly lower level of IL-6 (with t values of 2.34 and 2.32, respectively, P<0.05) and significantly lower free mtDNA copy number on PID 14 and 21 (with Z values of -2.28 and -2.34,respectively, P<0.05), significantly lower level of sTREM-1 on PID 7, 14, and 21 (with t values of 2.02, 2.94, and 3.72, respectively, P<0.05). Compared with those in severe burn diet enteral non-immunonutrition group, patients in severe burn diet enteral immunonutrition group had significantly lower level of IL-6 and sTREM-1 on PID 7, 14, and 21 (with t values of 2.15, 2.29, 2.47, 2.43, 2.07, and 2.32, respectively, P<0.05), and significantly lower free mtDNA copy number on PID 14 and 21 (with Z values of -2.49 and -2.21, respectively, P<0.05). During treatment, the sepsis incidences of patients in 2 common burn groups were similar (P>0.05), the sepsis incidences of patients in 2 severe burn groups were similar (P>0.05). The length of ICU stay of patients in severe burn diet enteral immunonutrition group was (11±3) d, which was significantly shorter than (14±3) d in severe burn diet enteral non-immunonutrition group (t=3.12, P<0.01). The length of hospital stay of patients in common burn diet enteral immunonutrition group was significantly shorter than that in common burn diet nutrition group (t=3.11, P<0.01). The length of hospital stay of patients in severe burn diet enteral non-immunonutrition group was similar to that in severe burn diet enteral immunonutrition group (P>0.05).  Conclusions  Enteral immunonutrition support therapy for adult burn patients at nutritional risk assessed by the modified 2nd NRS 2002 can better improve the nutritional status and the immune function of patients, reduce inflammatory response of the body, and shorten the length of hospital stay in common burn patients and the length of ICU stay in severe burn patients.

     

    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    SunYM, ZhuSN, LiSL, et al. Glutamine on critical-ill patients: a systematic review and meta-analysis[J]. Ann Palliat Med, 2021,10(2): 1503-1520. DOI: 10.21037/apm-20-702.
    [2]
    靳云云 运用改良的营养风险筛查工具指导烧伤患者营养治疗的回顾性调查 杭州 浙江大学 2015

    靳云云. 运用改良的营养风险筛查工具指导烧伤患者营养治疗的回顾性调查[D]. 杭州:浙江大学, 2015.
    [3]
    SingerM, DeutschmanCS, SeymourCW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016,315(8): 801-810. DOI: 10.1001/jama.2016.0287.
    [4]
    NilssonMI, MikhailA, LanL, et al. A five-ingredient nutritional supplement and home-based resistance exercise improve lean mass and strength in free-living elderly[J]. Nutrients, 2020,12(8):2391. DOI: 10.3390/nu12082391.
    [5]
    GammoneMA, RiccioniG, ParrinelloG, et al. Omega-3 polyunsaturated fatty acids: benefits and endpoints in sport[J]. Nutrients, 2018,11(1):46. DOI: 10.3390/nu11010046.
    [6]
    ChristieWW, HarwoodJL. Oxidation of polyunsaturated fatty acids to produce lipid mediators[J]. Essays Biochem, 2020,64(3):401-421. DOI: 10.1042/EBC20190082.
    [7]
    RaniM, SchwachaMG. Aging and the pathogenic response to burn[J]. Aging Dis, 2012,3(2):171-180.
    [8]
    刘军. 持续炎症-免疫抑制-分解代谢综合征的共识与争议[J]. 中华医学杂志,2019,99(13): 961-964. DOI: 10.3760/cma.j.issn.0376-2491.2019.13.001.
    [9]
    LiD,WahlqvistML,SinclairAJ.Advances in n-3 polyunsaturated fatty acid nutrition[J].Asia Pac J Clin Nutr,2019,28(1):1-5.DOI: 10.6133/apjcn.201903_28(1).0001.
    [10]
    SchulzeMB,MinihaneAM,SalehRNM,et al.Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases[J].Lancet Diabetes Endocrinol,2020,8(11):915-930.DOI: 10.1016/S2213-8587(20)30148-0.
    [11]
    RousseauG. Microbiota, a new playground for the omega-3 polyunsaturated fatty acids in cardiovascular diseases[J]. Mar Drugs, 2021,19(2):54. DOI: 10.3390/md19020054.
    [12]
    吴学军,马少军,赵翔. 糖皮质激素联合免疫球蛋白+烧伤救治技术治疗中毒性表皮坏死松解症10例[J]. 宁夏医学杂志,2018,40(4):364-365. DOI: 10.13621/j.1001-5949.2018.04.0364.
    [13]
    ShiJ, MuRQ, WangP, et al. The development of autoverification system of lymphocyte subset assays on the flow cytometry platform[J]. Clin Chem Lab Med, 2021,60(1):92-100. DOI: 10.1515/cclm-2021-0736.
    [14]
    BalkSJ, GottschlichEA, HolmanDM, et al. Counseling on sun protection and indoor tanning[J]. Pediatrics,2017,140(6):457-462. DOI: 10.1542/peds.2017-1680.
    [15]
    何小龙,李巍,李峥,等.不同程度烧伤患者淋巴细胞亚群的变化及其意义[J]. 陕西医学杂志,2018,47(11):1397-1399.DOI: 10.3969/j.issn.1000-7377.2018.11.009.
    [16]
    ZanderR, SchauderD, XinG, et al.CD4+T cell help is required for the formation of a cytolytic CD8+T cell subset that protects against chronic infection and cancer[J]. Immunity, 2019,51(6):1028-1042.e4. DOI: 10.1016/j.immuni.2019.10.009.
    [17]
    吕一鸣,黄玉军,俞雷来,等.重症急性胰腺炎患者出现肠源性感染的炎症指标与肠内营养支持治疗分析[J]. 中华医院感染学杂志,2017,27(2):373-376. DOI: 10.11816/cn.ni.2017-162956.
    [18]
    WangP,ZhangZX,YinB,et al.Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression[J].PeerJ,2022,10:e12680.DOI: 10.7717/peerj.12680.
    [19]
    SvetikieneM, RingaitieneD, VezelieneJ, et al. The efficacy of early postoperative enteral immunonutrition on T-lymphocyte count: a randomised control study in low-risk cardiac surgery patients[J].Clin Nutr,2021,40(2):372-379.DOI: 10.1016/j.clnu.2020.05.009.
    [20]
    CichockiF, BjordahlR, GaidarovaS, et al. iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy[J]. Sci Transl Med, 2020,12(568):eaaz5618. DOI: 10.1126/scitranslmed.aaz5618.
    [21]
    XiaoQQ, LiXT, LiY, et al. Biological drug and drug delivery-mediated immunotherapy[J]. Acta Pharm Sin B, 2021,11(4):941-960. DOI: 10.1016/j.apsb.2020.12.018.
    [22]
    BährI, SpielmannJ, QuandtD, et al. Obesity-associated alterations of natural killer cells and immunosurveillance of cancer[J].Front Immunol,2020,11:245.DOI: 10.3389/fimmu.2020.00245.
    [23]
    ZittiB,BrycesonYT.Natural killer cells in inflammation and autoimmunity[J].Cytokine Growth Factor Rev,2018,42:37-46.DOI: 10.1016/j.cytogfr.2018.08.001.
    [24]
    AbelAM, YangC, ThakarMS, et al. Natural killer cells: development, maturation, and clinical utilization[J].Front Immunol,2018,9:1869.DOI: 10.3389/fimmu.2018.01869.
    [25]
    ChiossoneL, DumasPY, VienneM, et al. Natural killer cells and other innate lymphoid cells in cancer[J].Nat Rev Immunol,2018,18(11):671-688. DOI: 10.1038/s41577-018-0061-z.
    [26]
    TanakaT,NarazakiM,KishimotoT. Interleukin (IL-6) immunotherapy[J].Cold Spring Harb Perspect Biol,2018,10(8):a028456.DOI: 10.1101/cshperspect.a028456.
    [27]
    顼小凤,王健祯,杨泽华.血浆游离线粒体DNA拷贝数与烧伤患者病情的相关性[J].山东大学学报(医学版),2021,59(11):61-66, 83.DOI: 10.6040/j.issn.1671-7554.0.2021.0222.
    [28]
    HungSK,LanHM,HanST,et al. Current evidence and limitation of biomarkers for detecting sepsis and systemic infection[J].Biomedicines,2020,8(11):494.DOI: 10.3390/biomedicines8110494.
    [29]
    StortzJA, MurphyTJ, RaymondSL, et al. Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis[J].Shock,2018,49(3):249-258.DOI: 10.1097/SHK.0000000000000981.
    [30]
    HoriguchiH, LoftusTJ, HawkinsRB, et al. Innate immunity in the persistent inflammation, immunosuppression, and catabolism syndrome and its implications for therapy[J].Front Immunol,2018,9:595.DOI: 10.3389/fimmu.2018.00595.
    [31]
    Kaźmierczak-SiedleckaK, DacaA, FolwarskiM, et al. Immunonutritional support as an important part of multidisciplinary anti-cancer therapy[J]. Cent Eur J Immunol, 2020,45(4):454-460. DOI: 10.5114/ceji.2020.103339.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(10)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3941) PDF downloads(52) Cited by()
    Proportional views
    Related

    Copyright © Chinese Journal of Burns京ICP备07035254号-14

    E-mail：shaoshangzazhi@163.com

    Website：https://zhsszz.xml-journal.net/

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return